High prevalence of nalidixic acid resistant, ciprofloxacin susceptible phenotype among clinical isolates of Escherichia coli and other Enterobacteriaceae

Diagnostic Microbiology and Infectious Disease

Volumn 42, Issue 4, 2002, Pages 257-261

  Ruiz, Joaquim ^a   Gómez, Julián ^a   Navia, Margarita M ^a   Ribera, Anna ^a   Sierra, Josep M ^a   Marco, Francesc ^a   Mensa, Josep ^a   Vila, Jordi ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; NALIDIXIC ACID;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL MUTATION; BACTERIAL STRAIN; BACTERIUM ISOLATE; CODON; CONTROLLED STUDY; ENTEROBACTERIACEAE; ESCHERICHIA COLI; GENETIC STRAIN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; TREATMENT FAILURE;

ANTI-INFECTIVE AGENTS; CIPROFLOXACIN; DNA GYRASE; DRUG RESISTANCE, MICROBIAL; ESCHERICHIA COLI; HUMANS; MICROBIAL SENSITIVITY TESTS; MUTATION; NALIDIXIC ACID; PHENOTYPE;

EID: 0036235219     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(01)00357-1     Document Type: Article

References (30)

1. Quinolones in the treatment of acute bacterial diarrhoeal diseases
2. In vivo selection of Klebsiella pneumoniae strains with enhanced quinolone resistance during fluoroquinolone treatment of urinary tract infections
3. Evaluation of pefloxacin, ofloxacin and ciprofloxacin in the treatment of thirty-nine cases of chronic osteomyelitis
4. Pharmacodynamics of a fluoroquinolone antimicrobial agent in a neutropenic rat model of Pseudomonas sepsis
5. Contribution of individual mechanisms to fluoroquinolone resistance in 36 Escherichia coli strains isolated from humans and animals
6. Chronic osteomyelitis caused by multi-resistant gram-negative bacteria: Evolution of treatment with newer quinolones after prolonged follow-up
7. Detection of decreased fluoroquinolone susceptibility in Salmonellas and validation of nalidixic acid screening test
8. A trial comparing low-dose, short-course ciprofloxacin and standard 7 day therapy with co-trimoxazole or nitruforantoin in the treatment of uncomplicated urinary tract infection
9. Treatment of Shigellosis: V. comparison of azithromycin and ciprofloxacin
10. Bacterial resistance of quinolones
11. Recomendaciones del grupo MENSURA para la selección de antimicrobianos en el estudio de la sensibilidad y criterios para la interpretación del antibiograma
12. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
13. Desarrollo de la resistencia a quinolonas en cepas de Escherichia coli aisladas de heces de pacientes cirróticos tratados con quinolonas
14. Ciprofloxacin resistance in clinical isolates of Salmonella typhimurium obtained from two patients
15. The region of the parE gene, homologous to the quinolone-resistant determining region of the gyrB gene, is not linked with the acquisition of quinolone resistance in Escherichia coli clinical isolates
16. Increased resistance in Campylobacter jejuni. A genetic analysis of gyrA gene mutation in ciprofloxacin resistant clinical isolates
17. Detección de la resistencia a quinolonas producida por mutaciones en la Ser-83 de la D.N.A-Girasa mediante P. C.R. y R. F.L. P. con HinfI en. Escherichia coli
18. High frequency of mutations at codon 83 of gyrA. gene of quinolone-resistant clinical isolates of Escherichia coli
19. Decreased permeability and enhanced proton-dependent active efflux in the development of resistance to quinolones in Morganella morganii strains
20. Mechanisms involved in the development of resistance to fluoroquinolones in Escherichia coli strains
21. Pharmacodynamic evaluation of factors associated with the development of bacterial resistance in acutely ill patients during therapy
22. The global epidemiology of resistance to ciprofloxacin and the changing nature of antibiotic resistance: A 10 year perspective
23. A novel, double mutation in DNA Gyrase A of Escherichia coli conferring resistance to quinolone antibiotics
24. Ciprofloxacin therapy in cystic fibrosis
25. Detection of mutations in parC in quinolone-resistant clinical isolates of Escherichia coli
26. Quinolone-resistance mutations in the topoisomerase IV parC gene of Acinetobacter baumannii
27. Mutation in the gyrA gene of quinolone-resistant clinical isolates of Acinetobacter baumannii
28. Association between double mutation in gyrA gene of ciprofloxacin-resistant clinical isolates of Escherichia coli and minimal inhibitory concentration
29. Investigation of quinolone resistance development of an Haemophilus influenzae strains isolated from a patient with recurrent respiratory infections treated with ofloxacin
30. Quinolone-resistant Salmonella typhi in Viet Nam: Molecular basis of resistance and clinical response to treatment